Ikaros is expressed in early hematopoietic progenitors and is required for lymphoid differentiation. In the absence of Ikaros, there is a lack of markers defining fate restriction along lympho-myeloid pathways, but it is unclear whether formation of specific progenitors or expression of their markers is affected. Here we use a reporter based on Ikaros regulatory elements to separate early progenitors in wild-type and Ikaros-null mice. We found previously undetected Ikaros-null lympho-myeloid progenitors lacking the receptor tyrosine kinase Flt3 that were capable of myeloid but not lymphoid differentiation. In contrast, lack of Ikaros in the common myeloid progenitor resulted in increased formation of erythro-megakaryocytes at the expense of myeloid progenitors. Using this approach, we identify previously unknown pivotal functions for Ikaros in distinct fate 'decisions' in the early hematopoietic hierarchy.
The long-term hematopoietic stem cell (HSC), capable of self-renewal and differentiation into many distinct lineages, is responsible for the lifelong generation of all blood and immune cell types [1] [2] [3] . Prospective isolation of HSCs and progenitor populations with conventional cell surface markers has identified rare, multipotent cells with defined lineage activities that in turn have been used to infer prevailing models of lineage restriction [4] [5] [6] . For example, the isolation of a common myeloid progenitor (CMP) and a common lymphoid progenitor (CLP), considered to be the respective roots of the erytho-myeloid and lymphoid lineages, has lent support to the idea of an early and strict separation of the lymphoid from the erythro-myeloid pathways.
The HSC compartment is operationally defined in the Lin -Sca-1 hi cKit hi (LSK) population that constitutes 0.1% of adult bone marrow cells and contains both long-term and short-term HSCs, also known as multipotent progenitors 7, 8 . The use of additional markers, including CD34 and the Flt3 receptor tyrosine kinase, has separated longterm HSCs (Lin -Sca-1 hi c-Kit hi CD34 -Flt3 neg-lo ) from short-term HSCs (Lin -Sca-1 hi c-Kit hi CD34 + Flt3 neg-lo ) and more short-lived lymphoidprimed progenitors (Lin -Sca-1 hi c-Kit hi CD34 + Flt3 + ) [9] [10] [11] [12] .
Restricted erythro-myeloid progenitors are present in the more abundant Lin -Sca-1 -c-Kit hi (LK) population (0.6-1% of the bone marrow) that can be further subdivided into a CMP population (CD34 + FcgR lo ) and its more restricted progeny of megakaryoerythrocyte progenitors (MEPs; CD34 -FcgR lo ) and granulo-monocyte progenitors (GMPs; CD34 + FcgR hi ). A restricted CLP capable of B cell, T cell and natural killer cell differentiation has been purified as a Lin -Sca-1 lo c-Kit lo interleukin receptor 7a-positive (IL-7Ra + ) population 4 . Its potential predecessor, the early lymphoid progenitor, was demonstrated in low numbers in the LSK compartment by a reporter under control of the recombination-activating gene 1 (Rag1) locus, which is expressed early in lymphocyte development 13 . Other studies of T cell ontogeny have shown a progenitor with a mainly T cell-restricted potential that, unlike the CLP, is readily detected in the circulation, thus challenging the idea that the CLP is the root of all lymphoid lineages 14, 15 . In addition, subcategorization of HSCs according to Flt3 expression has demonstrated the existence of lymphoid-primed multipotent progenitors (LMPPs) with the ability to generate lymphoid and myeloid but not erythroid progeny and has cast doubt on the strict separation of the erythro-myeloid from the lymphoid lineages at an earlier step of the pathway 16 . However, the physiological contributions of these alternative pathways and their underlying genetic controls remain elusive.
Nuclear regulators expressed in early progenitors control cell fate 'decisions' in development presumably by modulating expression of lineage-specific genes either in a stochastic way or in response to environmental cues [17] [18] [19] [20] [21] . Of these, the Ikaros protein family of Krüppel-type zinc finger DNA-binding factors is essential for normal lymphocyte development and homeostasis [22] [23] [24] [25] [26] . Ikaros-null mice lack all B cells, natural killer cells and fetal T cells. The defect in lymphocyte development occurs very early in hematopoietic ontogeny, possibly before the generation of CLPs 14, 24 . Notably, and in contrast to the persistent block in B cell and natural killer cell development, a few early T cell progenitors are detected in the Ikaros-deficient thymi, and mature T cells are exported to the periphery 24 . Myeloid differentiation is not impaired in Ikaros-null mice, as mixed-myeloid, granulocytemacrophage and macrophage progenitors and their mature progeny are present in normal to increased numbers compared with those of their wild-type littermates 27 .
HSCs in Ikaros-null mice lack Flt3, which is normally upregulated during the transition from short-term HSC to LMPP 16, 27 . Flt3 and its cognate ligand regulate the ability of HSCs to repopulate bone marrow in competitive repopulation conditions as well as their ability to differentiate into lymphoid progenitors, properties that are both impaired in the absence of Ikaros [27] [28] [29] . Thus, Ikaros, which is normally present in hematopoietic progenitors, can regulate their developmental restriction, possibly by modulating expression of lineage regulators like Flt3. Ikaros and its family members are thought to regulate the expression of lineage-specific genes by targeting chromatinremodeling activity in their vicinity. That hypothesis is in part supported by the stable association of Ikaros proteins with components of the NuRD and the SWI-SNF chromatin-remodeling complexes and in part by their association with the local chromatin of lineage-specific genes [30] [31] [32] .
Hematopoietic cell expression of Zfpn1a1, the gene that encodes Ikaros, is controlled by a complex network of regulatory regions composed of elements with both common and distinct activities in the lymphoid, myeloid and erythroid lineages. The minimal combination of a promoter and its downstream intronic region, mainly active in B cells, together with one of the Ikaros enhancers can reliably recapitulate Ikaros expression in differentiating and mature lymphoid and myeloid cells 33 . Further investigation of the activity of the Ikaros expression cassette in the HSC and progenitor compartment has provided reliable separation of HSC and lympho-myeloid progenitor populations in the absence of their defining markers. Here we evaluate the effects of Ikaros deficiency in the early hematopoietic hierarchy and demonstrate new and unexpected functions for Ikaros in this developmental process.
RESULTS

Subcategorization of LSK progenitors using an Ikaros reporter
Given that Ikaros contributes to cell fate decisions during early hematopoiesis, we sought to determine the regulatory elements responsible for its expression in HSCs and their immediate progeny. A transgenic mouse strain expressing green fluorescent protein under control of an Ikaros promoter-enhancer along the lymphoid and myeloid pathways has been described 33 . Using these 'Ikaros-green fluorescent protein' (called simply 'GFP' here) reporter mice, we further investigated the activity of these Ikaros regulatory elements in HSC-and progenitor-enriched bone marrow populations.
The LSK population containing long-term and short-term HSCs had a bimodal distribution of GFP expression (Fig. 1a) . We obtained a statistical measure of reporter distribution in the LSK cells by analyzing a cohort of mice ( Supplementary Fig. 1 online) . Two thirds of LSK cells were GFP neg-lo and the remaining one third was GFP + . Examination of endogenous Ikaros isoform expression in the LSK subsets showed a similar trend of upregulation from GFP neg-lo to GFP + cells (Fig. 1b) .
To determine whether the LSK subsets were functionally different, we first analyzed their expression of lineage-specific genes that are 'promiscuously' expressed in wild-type HSCs and multipotent progenitors 13, 34, 35 (Fig. 1c) . The LSK GFP neg-lo population had low or no expression of the early myeloid lineage-promoting genes Sfpi1, Gfi1b, Csf3r, Csf2ra, Cebpa, Mpo and Csf1r. There was higher expression of the erythroid lineage-promoting genes Gata1, Gata2, Nfe2 and Mpl in the LSK GFP neg-lo population, but we did not detect expression of genes encoding the erythropoietin receptor (Epor) or b-major globin (Hbb-b1), which are present in more differentiated erythroid cell types (Fig. 1c) . The LSK GFP + population had a reciprocal pattern of gene expression, with substantial upregulation of myeloid-specific genes and downregulation of erythroid-specific genes (Fig. 1c) . Expression of the lymphoid lineage-promoting gene Flt3 was highest in the LSK GFP + subset that also expressed the early lymphoid-specific genes Rag1, Zfpn1a3 and Il7r but not Pax5 or Ebf1 (Fig. 1c and Supplementary Fig. 2 online) . In contrast, the LSK GFP neg-lo subset expressed less Flt3 and had no detectable expression of lymphoid genes (Fig. 1c) . The gene expression profiles of these two subsets indicates that the LSK GFP neg-lo subset is more primitive in nature than the LSK GFP + subset, which has upregulated lymphoid-and myeloid-specific genes and downregulated HSC-specific genes promoting erythroid differentiation.
To determine whether these differences in gene expression also 'translated' into functional distinctions, we evaluated the LSK GFP subsets for their differentiation potential. We cultured low numbers of LSK cells in mixed-cytokine conditions, including stem cell factor, IL-3, IL-6, IL-11, erythropoietin, thrombopoietin and granulocytemacrophage colony-stimulating factor, which promote differentiation into many myeloid and erythroid lineages. Both the LSK GFP neg-lo and LSK GFP + subsets produced colonies with very high proliferative potential, as has been reported for HSCs and multipotent progenitors 36, 37 (Fig. 1d,e) . Most of the LSK GFP neg-lo colonies (66%) were of mixed-myeloid origin that included erythrocytes and megakaryocytes (Fig. 1d,e, top) . Microscopic examination of mixed colonies derived from single LSK GFP neg-lo cells showed the presence of both GFP -and GFP + clusters of cells of erythroid and myeloid lineage morphology, respectively (Fig. 1e, top left) . We further verified the identity of these cells by May-Giemsa staining (Fig. 1e, top right) . In contrast to the LSK GFP neg-lo colonies, most LSK GFP + colonies were composed of GFP + granulocytes and macrophages (granulocyte-macrophage and macrophage), and very few (4%) were of mixed-myeloid lineage (Fig. 1d,e, bottom) . We also tested the LSK GFP subsets in cultures supplemented only with erythropoietin, which promotes the differentiation of only committed erythroid progenitors. We detected no substantial colony-forming unit-erythroid (CFU-E) activity in either subset (Fig. 1d) , consistent with the primitive nature of the LSK GFP neg-lo population, the loss of erythroid potential in the LSK GFP + (Fig. 1d) and the lack of Epor expression in both LSK subsets (Fig. 1c) . These studies indicate that the Ikaros reporter used here effectively separates the HSC compartment into multipotent progenitors with myelo-erythroid potential and more committed progenitors with myeloid but not erythroid potential.
We also tested the lymphoid potential of the LSK subsets in conditions supporting B cell or T cell development 38 . T cell development can be recapitulated in vitro with many progenitor types cultured together with OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1) 38 . In these conditions, both the LSK GFP neg-lo and LSK GFP + subpopulations showed robust B cell and T cell differentiation in vitro, in which the kinetics of lymphocyte specification indicated a progenitor-progeny relationship ( Fig. 1f and Supplementary Fig. 3 online). By day 20 of OP9-DL1 culture, both LSK GFP neg-lo and LSK GFP + subpopulations had progressed to the double-negative 4 (DN4) stage, but higher DN2/DN3 and DN3/DN4 ratios for GFP neg-lo subpopulations than for GFP + subpopulations indicated that the latter were developmentally more advanced (Fig. 1f, middle) . Doublepositive thymocytes were also readily detectable in the LSK GFP + but not the LSK GFP neg-lo cultures (Fig. 1f, bottom) . The kinetics with which the LSK subsets progressed through B cell ontogeny showed a similar trend. Although by day 8 both subpopulations gave rise to B220 + cells ( Supplementary Fig. 3 online) , by day 12 most B220 + cells in the LSK GFP + cultures were CD19 + , whereas those in the GFP neg-lo cultures were CD19 - (Fig. 1f, top) . Nonetheless, by day 16 there was a similar ratio of B220 + CD19 + to B220 + CD19 -cells in both cultures ( Supplementary Fig. 3 online) . Thus, the two LSK GFP subsets had both B cell and T cell differentiation potential with kinetics of differentiation, indicating a progenitor-progeny relationship.
The developmental potential of the LSK GFP + subset is reminiscent of the LMPPs that were identified in the LSK population by high Flt3 expression 16 . The LSK GFP subpopulations had considerable differences in Flt3 expression: LSK GFP + cells had high expression of Flt3, whereas the LSK GFP neg-lo cells had much lower expression of Flt3 ( Fig. 1g and Supplementary Fig. 4 online) . Thus, high expression of the Ikaros reporter or Flt3 in the LSK compartment identified more developmentally restricted progenitors with lymphoid and myeloid potential but no erythroid potential ( Supplementary Fig. 5 online) .
Ikaros expression allows subcategorization of erythro-myeloid progenitors Given the differential activity of the Ikaros reporter in the HSC compartment and its ability to identify functionally distinct progenitors, we assessed its activity in more restricted erythro-myeloid progenitors. There was bimodal distribution of reporter expression in the LK population, but here GFP hi cells represented the main subpopulation, whereas GFP -cells were in the minority ( Fig. 2a and Supplementary Fig. 1 online) . In contrast to its activity in the LSK population, reporter activity in the LK population did not recapitulate endogenous Ikaros expression, indicating that additional regulatory elements are required for proper expression in these cells (Fig. 2b) .
We first assessed functional differences between the LK GFP subsets by analyzing the expression of lineage differentiation markers. The LK GFP -fraction expressed genes specific for the erythro-megakaryocyte lineage (Fig. 2c) . Notably, of the erythro-megakaryocyte markers analyzed, Gata1, Epor and Hbb-b1 were upregulated in the LK GFPpopulation relative to expression in the LSK GFP neg-lo population, whereas Mpl and Gata2 (refs. 34, 39) , which are expressed in long-term HSCs, were downregulated (Figs. 1c and 2c). In contrast, genes associated with granulocyte-macrophage differentiation were either not expressed or were detected in trace amounts (Fig. 2c ). There was a mostly reciprocal expression profile in the LK GFP hi population. Expression of genes involved in granulocyte-macrophage differentiation was greatly enhanced, whereas expression of erythro-megakaryocyte genes was absent or substantially reduced (Fig. 2c) . In the LK GFP int population, we detected a combination of erythroid and myeloid genes, reflecting either an incomplete separation of erythroid from myeloid progenitors or the presence of mixed-lineage progenitors in this subset (Fig. 2c) . Notably, small amounts of Flt3 and the early lymphoid-lineage genes Zfpn1a3 and Il7r were also detected in the LK GFP hi and GFP int but not the GFP -subset (Fig. 2c) . That finding was not due to contamination with either the LSK GFP + or CLP population ( Supplementary Fig. 2 online) . A Flt3 + subset of LK myeloid progenitors shown before to contain in vivo lymphoid reconstitution activity was probably responsible for that gene expression profile 40 .
We next evaluated LK GFP subsets for erythro-myeloid differentiation potential. After culture with erythropoietin, there was a progressive increase in CFU-E and mature burst-forming uniterythroid (BFU-E) activity from the LK GFP int to the LK GFP -subset, whereas the LK GFP hi subset had no detectable activity (Fig. 2d, left) . In mixed-cytokine conditions (Fig. 2d, right) , the LK GFP -population produced mostly BFU-E, erythro-megakaryocyte and megakaryocyte colonies and some mast cell colonies, but no granulocyte-macrophage colonies. In contrast, most colonies produced from the LK GFP hi population were of the macrophage and granulocyte-macrophage lineages. The granulocyte-macrophage colonies produced by the LK GFP hi population were substantially smaller than those produced by the LSK GFP + population, indicating a decreased proliferative potential (Figs. 1e, left, and 2e, bottom right). The LK GFP int population produced the greatest variety of colonies, including BFU-E, erythro-megakaryocyte, megakaryocyte, macrophage, granulocytemacrophage and mast cell. A small fraction of these colonies contained erythroid and myeloid cells, indicating the presence of less-restricted progenitors with CMP-like multilineage potential. Notably, the mixedlineage colonies in the LK GFP int subset were much smaller than those in the LSK GFP neg-lo subset, indicating a limited proliferative capacity.
To provide an independent line of support for the identity of these progenitors, we analyzed the LK GFP subsets for expression of CD34 and FcgRII-III (FcgR), markers that define distinct myeloerythroid progenitors. We found the following pattern: LK GFP -CD34 -FcgR lo , LK GFP int CD34 int FcgR int and LK GFP hi CD34 + FcgR hi ( Supplementary Figs. 4 and 5 online). Our assignment of MEP, CMP and GMP progenitor activity to the LK GFP -, GFP int and GFP hi subsets is thus consistent with their previous classification using conventional cell surface markers.
Identification of LMPPs in Ikaros-null LSK cells
Although Ikaros-null mice have substantial defects in lymphopoiesis, efforts to study these effects in early progenitors have been hampered by the potential deregulation of markers that define these cells. Given the ability of the Ikaros reporter to allow identification of LMPPs in a way similar to Flt3 (Fig. 1g) , we assessed its expression in the Ikarosnull LSK compartment, which lacks appreciable amounts of Flt3 and possibly LMPPs (Fig. 3a) . In Ikaros-null LSK cells, the Ikaros reporter was expressed in a bimodal pattern similar to that noted in wild-type LSK cells (Fig. 3a and Supplementary Fig. 1 online) , indicating the presence of putative LMPPs despite the lack of Flt3 expression.
We first evaluated possible subdivision of the Ikaros-null LSK compartment by the Ikaros reporter by gene expression. In Ikarosnull cells, as in wild-type cells, expression of granulocyte-macrophage markers was present mainly in the LSK GFP + compartment (Fig. 3b) . Of the few lymphoid differentiation markers normally expressed in LSK GFP + cells, Zfpn1a3 but not Flt3, Il7r or Rag1 was present (Fig. 3b) . Markers of erythro-megakaryocyte differentiation were present mainly in the Ikaros-null LSK GFP neg-lo subset and not the GFP + subset, as with their wild-type counterparts (Figs. 1c and 3b) . Thus, the Ikaros reporter subdivides the Ikaros-null LSK compartment into subsets with distinct lineage-specific gene profiles that resemble those of their wild-type counterparts.
We next examined Ikaros-null LSK GFP subsets for differentiation into various hematopoietic lineages. In vitro cultures of the LSK GFP neg-lo subset were composed of mixed-lineage and granulocytemacrophage colonies, as with wild-type cells (Fig. 3c,d) . However, the GFP neg-lo subset yielded a substantial increase in the number of erythro-megakaryocyte, granulocyte-macrophage and macrophage colonies relative to that of wild-type precursors, whereas there was a corresponding reduction in mixed-lineage colonies containing erythrocytes (Fig. 3c) . Similar to its wild-type counterpart, the mutant LSK GFP + compartment was composed mainly of granulocytemacrophage progenitors; however, the colony size was smaller, indicating a reduced proliferative potential (Fig. 3d, bottom left) .
To extend insight into the cell-type composition of the Ikaros-null mixed-cytokine cultures, we analyzed their expression of lineagespecific surface markers. In both the Ikaros-null and wild-type LSK GFP + cultures, most cells were myeloid (Mac-1 + ) in origin. However, whereas in wild-type cultures most of these cells were GFP hi , in Ikarosnull cultures they were GFP int , possibly indicating a difference in their developmental state. Ikaros-null and wild-type LSK GFP neg-lo cultures yielded cells (62-79%) that were of myeloid (Mac-1 + ) origin with intermediate to high GFP expression, acquired during in vitro Fig. 1 online) . The LK GFP -, GFP int and GFP hi subsets were sorted and were used in subsequent studies. (b) Semiquantitative RT-PCR analysis of endogenous Zfpn1a1 expression (as in Fig. 1b) . (c) Semiquantitative RT-PCR analysis of the expression of lineage-specific genes in the LK GFP -, GFP int and GFP hi subsets (as in Fig. 1c) . (d) The erythro-myeloid differentiation potential of the LK GFP subsets, assessed in erythropoietin and mixed-cytokine cultures (as described in Fig. 1d ). m.BFU-E, mature BFU-E; G, granulocyte; Mc, mast cell. Data are representative of more than five independent studies of LK GFP subsets. (e) Microscopy of LK GFP colonies: an erythromegakaryocyte colony from an LK GFP -culture (top left), a mixed colony from an LK GFP int culture (top right) and a macrophage colony from an LK GFP hi culture (bottom left), stained with May-Giemsa and visualized by brightfield microscopy; and a macrophage colony from an LK GFP hi culture (bottom right), visualized by fluorescence microscopy. Original magnification, Â600 (top row and bottom left) and Â50 (bottom right). Images are representative of more than 5 Â 10 2 colonies.
differentiation (Fig. 3e) . Ikaros-null LSK GFP neg-lo cultures had higher expression of the megakaryocyte-lineage marker CD41 (Fig. 3e) , consistent with the increase in erythro-megakaryocyte and megakaryocyte colonies in this population (Fig. 3c) .
We next examined the lymphoid differentiation potential of the Ikaros-null LSK subsets. When we cultured Ikaros-null LSK subsets together with OP9-green fluorescent protein cells, they failed to undergo B cell differentiation (data not shown). Ikaros-null LSK GFP + populations showed limited expansion in T cell differentiation conditions, and their kinetics of differentiation were also delayed compared with those of their wild-type counterparts. T cell-restricted precursors at the DN2-DN3 stage were apparent by day 20 in the mutant, in contrast to their appearance at days 12-14 in wild-type cultures ( Supplementary Fig. 3 online) . The subsequent transition of Ikaros-null DN precursors to the double-positive stage of differentiation was apparent by day 28, in contrast to transition at day 16 in wild-type cultures ( Fig. 3f and Supplementary Fig. 3 online) . Limiting-dilution analysis of the Ikaros-null LSK GFP + subset showed a reduction in T cell progenitor activity of more than 20-fold relative to that of wild-type cells (Supplementary Table 1 online) . Thus, analysis of the Ikaros-null LSK cells using the Ikaros reporter indicated that LMPPs can be generated in the absence of Ikaros and Flt3. These mutant LMPPs can differentiate normally along myeloid but not lymphoid pathways ( Supplementary Fig. 5 online) .
Ikaros is a pivotal differentiation factor in LMPPs
Having identified an LMPP population in Ikaros-null bone marrow, we sought to determine whether the output of lymphoid and myeloid progenitors was altered at this stage in development. Thus, we assessed the effects of Ikaros deficiency in single LMPP cells. We tested the combined lympho-myeloid potential of single LSK GFP + progenitors from wild-type and Ikaros-null bone marrow after limited in vitro population expansion. Most wild-type LSK GFP + progenitors (53%) grown initially in the presence of stem cell factor, Flt3 ligand and IL-7 ( Fig. 4a) gave rise to colonies with combined lympho-myeloid potential. Colonies with only lymphoid (27%) or myeloid (20%) potential were also present. When the initial expansion of LSK GFP + progenitor populations was done in the absence of IL-7 (Fig. 4a) , most (71%) clones had only myeloid potential. Colonies with combined lympho-myeloid potential were still detected but they were much fewer in number (29%). We did not obtain colonies with only lymphoid potential in these conditions. The Ikaros-null LSK GFP + progenitors produced clonal expansion numbers similar to those of their wild-type counterparts (Fig. 4a) , with, however, a very distinct differentiation outcome. Whether grown in the presence or absence of IL-7, the Ikaros mutant progenitors gave rise to mostly myeloid colonies (Fig. 4a) . Only a very small fraction of these colonies (4%) retained lympho-myeloid potential in either condition. Furthermore, the Ikaros-null LSK GFP + lympho-myeloid clones had only T cell potential and no B cell potential. Many fewer colonies with T cell potential were detected from the Ikaros-null LMPPs, whereas there were many more cultures with myeloid potential than with their wild-type counterparts (Fig. 4b) .
These single-cell assays collectively demonstrate a change in the differentiation potential of LMPPs in the absence of Ikaros. The LMPP seems to be fairly plastic and can be polarized to differentiate along the lymphoid or myeloid pathways depending on cytokine context. In the absence of Ikaros, the LMPP is stripped of its B cell potential and its T cell potential is reduced considerably, but its myeloid potential remains intact.
CMPs require Ikaros for myeloid differentiation
Given the involvement of Ikaros in LMPP differentiation, we assessed its potential effects on the CMP and its progeny (Fig. 5) . Analysis of the Ikaros-null LK compartment with CD34 and FcgR markers showed an unexpected change in progenitor distribution. The MEP population was increased, whereas the GMP population was decreased (Fig. 5a) . These data are in contrast to published analyses 27 and our present data of unfractionated Ikaros-null bone marrow (Fig. 5e) indicating normal to increased multilineage, granulocyte-macrophage and megakaryocyte progenitors and decreased early erythroid (BFU-E but not CFU-E) progenitors 27 .
Given the possibility for Ikaros-mediated deregulation of the CD34 and FcgR markers, we tested GFP expression in the LK compartment. In mutant LK cells (and in contrast to LSK cells), the Ikaros reporter distribution was altered substantially. The LK GFP hi subset that predominated in wild-type populations was greatly reduced, whereas the LK GFP -subset was increased ( Fig. 5b and Supplementary Fig. 1 online) . To determine whether the Ikaros reporter allowed subcategorization of Ikaros-null and wild-type LK cells in a similar way, we tested these subsets for expression of lineagespecific markers. In Ikaros-null as in wild-type progenitors, we detected expression of erythro-megakaryocyte markers in the GFPbut not in the diminished GFP hi population, and the expression of granulocyte-macrophage markers showed a reciprocal pattern (Fig. 5c) . The LK GFP int subset expressed markers of both erythroid and myeloid differentiation except for the gene encoding C/EBPa, whose expression was greatly reduced (Fig. 5c) . Thus, the gene expression profiles from Ikaros-null LK GFP subsets were similar to those of their wild-type counterparts.
To account for changes in the Ikaros-null LK progenitors, we assessed their differentiation properties. As with their wild-type counterparts (Fig. 2d) and as predicted by their gene expression profile (Fig. 5c) , the Ikaros-null LK GFP -colonies contained BFU-E, megakaryocyte and erythro-megakaryocyte progenitors, whereas the Ikaros-null (and diminished) LK GFP hi colonies contained granulocyte-macrophage progenitors (Fig. 5d,f) . We detected multilineage colonies in the Ikaros-null LK GFP int colonies, as well as colonies of more restricted potential. Here, we detected an unexpected increase in megakaryocyte differentiation in both mixed-lineage as well as in the more developmentally restricted megakaryocyte and erythro-megakaryocyte colonies (also seen in the LK GFP -subset). Further analysis of these colonies showed an increase in the megakaryocyte-specific marker CD41, consistent with the increase in megakaryocyte differentiation (Fig. 5f) . The large decrease in Mac-1 + cells also indicated a substantial defect in myeloid differentiation of the CMP population present in this compartment (Fig. 5d,f) . Thus, the Ikaros reporter can be used to reliably subdivide the Ikaros-null LK compartment into subsets containing CMPs, MEPs and GMPs, showing a substantial decrease in GMP production from CMPs. These studies indicate that Ikaros is not only required at the LMPP stage for lymphoid differentiation but also promotes cell fate 'decisions' at several branch points of the myelo-erythroid pathway ( Supplementary Fig. 5 online) . At the CMP stage, it directs myeloid differentiation, and further 'downstream' at the more restricted MEP stage it directs erythroid differentiation. 
DISCUSSION
Here we have addressed the function of Ikaros in early hematopoietic lineage restriction. We have used an Ikaros-based reporter that distinguishes early hematopoietic progenitors independently of their characteristic cell surface markings to analyze Ikaros-null progenitors. These studies have shown that although Ikaros is not required for initial segregation of erythro-myeloid and lympho-myeloid progenitors, it is required for their subsequent 'choice' of cell fate. Finally, its depletion in these two cell types causes substantial defects along the lymphoid and erythroid lineages, respectively. The reporter driven by Ikaros regulatory elements demonstrated a bimodal distribution in the hematopoietic stem cell (LSK) compartment that identified two main progenitor populations, both with high proliferative potential but with distinct differentiation properties. The GFP neg-lo progenitors were mainly multipotent with erytho-myeloid and lymphoid potential, whereas the GFP + subset was more lineage restricted, with progenitors of lympho-myeloid potential but no erythroid potential. The gene expression profiles of these subsets also correlated with characterization based on differentiation properties. We achieved a similar separation of LMPPs from the LSK compartment on the basis of Flt3 expression, which correlated with Ikaros reporter activity and expression of the endogenous Ikarosencoding Zfpn1a1 locus.
Flt3 expression, a defining characteristic of LMPPs, is actually dependent on Ikaros activity in these cells. The LSK population in Ikaros-null mice lacks Flt3. Although that finding could indicate an absence of the LMPP subset, use of the Ikaros reporter here demonstrated the presence of mutant LMPPs that were generated in the absence of Flt3 activity and that would otherwise be undetectable. In the absence of Flt3, Ikaros-null LMPPs are unable to undergo normal lymphoid differentiation. In culture systems that promoted lymphocyte development, they failed to generate B cells but generated T cells, albeit at a frequency that was reduced by at least one order of magnitude and with delayed kinetics. Ikaros-null LMPPs readily underwent myeloid differentiation even in conditions that normally promote lymphoid development. Those conditions involve IL-7R signaling, and the inability of mutant LMPPs to express or induce IL-7Ra is a likely cause for this defect. Given that Ikaros-null mice have T cell but no B cell progenitors and that they lack CLPs, it is likely that LMPPs are the source of T cell differentiation in these mice. It is Supplementary Fig. 1 online) . (c) Semiquantitative RT-PCR analysis of Ikaros-null LK GFP subsets for lineage-specific markers (as in Fig. 1c ). (d) Erythro-myeloid differentiation potential of Ikaros-null LK GFP subsets. LK GFP subsets were sorted from wild-type and Ikarosnull bone marrow and were assayed in mixedcytokine conditions (as in Fig. 1d ). ) contained more primitive progenitors with erythro-myeloid mixed-lineage activities similar to those of the CMP population. Both the LK mixed-myeloid and GMP-restricted progenitors had much less proliferative potential than that of progenitors with similar differentiation properties in the LSK compartment. Gene expression analysis of the three LK GFP subsets provided independent support for their state of differentiation. Analysis of the LK GFP subsets with CD34 and FcgRII-III, used before to identify distinct populations of erythro-myeloid progenitors 5, 42 , showed an expression pattern consistent with their differentiation potential, indicating that the Ikaros reporter can effectively substitute for expression of these markers in identifying cells. Notably, we also achieved separation of progenitors using the Ikaros reporter on genetic backgrounds that affect expression of these markers.
Unexpectedly, examination of Ikaros-null erythro-myeloid progenitor populations showed substantial depletion of GMPs. In the Ikarosnull mutants, the observed reduction of GMPs derived from CMPs despite the presence of normal myeloid progenitor activity in unfractionated bone marrow was inconsistent with the classical CLP-versus-CMP model of hematopoietic hierarchy. The apparent absence of LMPPs in Ikaros-null bone marrow based on Flt3 expression made that observation difficult to reconcile with the more recent LMPPversus-MEP model of hematopoiesis 16 . However, the identification of an Ikaros-null LMPP devoid of Flt3 expression and with increased ability to generate GMPs but not pro-B cells and possibly not CLPs explains the normal complement of GMPs in the mutant bone marrow. In contrast to the Ikaros-null LMPPs, the Ikaros-null CMPs produced fewer GMPs and instead generated more MEPs. Thus, our studies based on two independent genetic approaches centered on Ikaros support a third model by which a major bifurcation 'downstream' of the short-term HSC gives rise to either an erythro-myeloid progenitor (CMP) or a lympho-myeloid progenitor (LMPP) as a gateway into two independent myeloid pathways. Although we have not addressed which of the two myeloid progenitors (LMPPs or CMPs) is the main contributor to the myeloid lineage in the presence of Ikaros, we have demonstrated that LMPPs are able to generate physiological numbers of myeloid cells in an intact animal model in the absence of Ikaros. Our studies have also shown that in the erythro-megakaryocyte pathway, Ikaros is required for the restriction of MEPs to the erythroid lineage. Ikaros deficiency results in a large expansion of megakaryocyte populations at the possible expense of erythroid progenitors. That result is consistent with the reported increase in mature megakaryocyte cells in the spleens of Ikaros-null and dominant negative mutant mice 23, 43 .
The contrasting effects of Ikaros on fate 'choices' in distinct progenitor populations (such as LMPPs and CMPs) demonstrate the complexity of its function and emphasize the need to evaluate gene expression in highly defined populations. With the ability to isolate these distinct progenitor populations provided by the Ikaros reporter, it is now possible to identify the genes regulated by Ikaros in LMPPs, CMPs and MEPs to further delineate the genetic controls of lineage 'choice' . The demonstrated deregulation of genes encoding lymphoidpromoting factors such as Flt3 and IL-7Ra (as well as of other early lymphoid-specific genes such as Rag1) identifies excellent candidates for meditating the ability of Ikaros to promote the lymphoid fate at the LMPP stage. Positive regulation of myeloid-promoting factors such as C/EBPa and or negative regulation of erythroid-and megakaryocytepromoting factors may be responsible for the altered myelo-erythroid and megakaryo-erythroid fate 'choices' at the CMP and MEP stages, respectively. The use of Ikaros-based reporters to delineate the distinct functions of the Ikaros gene products in different cell types opens many new avenues for future investigation and are rapidly filling in the 'terra incognita' on the map of hematopoietic differentiation that is the genetic hierarchy of early lineage 'decisions' .
METHODS
Mice. Transgenic mice (B-p-GFP-C line; C57BL/6 Â C3H) 33 and Ikaros-null mice (I74 line; C57BL/6 Â 129SV) 24 were bred and maintained in pathogen free conditions in the animal facility of Massachusetts General Hospital (Charlestown, Massachusetts). Mice were 4-12 weeks of age at the time of analysis. All animal experiments were done according to protocols approved by the Subcommittee on Research Animal Care at Massachusetts General Hospital (Charlestown, Massachusetts) and were in accordance with the guidelines set forth by the National Institutes of Health.
Antibodies. All antibodies were purchased from BD PharMingen or Caltag. Antibodies to the following were used (specific clones in parentheses): CD3 (17A2), CD4 (L3T4), CD5 (53-7. Flow cytometry and cell sorting. Bone marrow cells were isolated and immunolabeled as described 27 . Bone marrow cells were collected from femurs and tibias and red blood cells were lysed with ACK buffer (0.15 M ammonium chloride, 10 mM potassium bicarbonate and 0.1 mM EDTA). Lineage-positive cells were subsequently labeled with antibodies to the lineage markers Ter119, B220, Mac-1, Gr-1, 7/4, CD3, CD5, CD8a, CD8b, CD19, TCb, TCRgd and DX5 and were removed with magnetic beads coated with sheep antibody to rat immunoglobulin G (IgG; Dynal). The remaining cells were labeled with phycoerythrin-Cy5.5-conjugated antibody to rat IgG to label any remaining lineage-positive cells. Cells were then labeled with allophycocyanin-conjugated anti-c-Kit and phycoerythrin-conjugated anti-Sca-1 before flow cytometry and cell sorting. For additional Flt3 visualization, samples depleted of lineage-positive cells were labeled with biotin-conjugated antibody to rat IgG or magnetic depletion was done with biotin-conjugated lineage antibodies followed by staining with allophycocyanin-cyanine 7-conjugated streptavidin. Lineage-negative cells were then labeled with allophycocyanin-anti-c-Kit, phycoerythrin-Cy5.5-anti-Sca-1 and phycoerythrin-antiFlt3 before flow cytometry. For staining of CMPs, GMPs and MEPs, bone marrow cells were collected and samples were magnetically depleted as described above with lineage-specific antibodies to Ter119, B220, CD19, IgM, Gr-1, 7/4, CD3, CD4, CD8a, TCRgd and NK1.1. Lineage-negative cells were analyzed with allophycocyanin-anti-c-Kit, phycoerythrin-Cy5.5-anti-Sca-1, phycoerythrin-anti-FcgRII-III and fluorescein isothiocyanate-anti-CD34. CLPs were isolated as described 4 . A two-laser FACSCanto (Becton Dickinson), a twolaser FACSCalibur (Becton Dickinson) or a three-laser MoFlo (Cytomation) was used for flow cytometry; a three-laser MoFlo was used for cell sorting. The resulting files were uploaded to FlowJo (TreeStar) for further analysis.
RT-PCR assays. Total RNA was prepared from approximately 1 Â 10 3 to 2 Â 10 4 sorted cells using TriZol reagent (Invitrogen). The SuperScript II FirstStrand Synthesis System for RT-PCR (Invitrogen) was used to synthesize cDNA. The cDNA products were quantified with real-time PCR using SYBR Green PCR Master Mix (Applied Biosystems) and Actb (encoding b-actin) primer pairs. For subsequent PCR, the amount of cDNA from different populations was normalized based on Actb signals. For labeling of reaction products, [a-32 P]dCTP was added to each PCR. PCR products were visualized with a Phosphorimager screen (Molecular Dynamics) or with Biomax MS film (Kodak). Each reaction contained cDNA from approximately 10-20 cells. Fivefold more template was used in reactions done to detect lymphoid-specific genes. Primer sequences and expected product sizes are in Supplementary Table 2 online.
In vitro methylcellulose colony-forming cell assay. For the CFU-E and mature BFU-E assay, 5 Â 10 2 cells sorted from the LK GFP subsets, 2 Â 10 2 cells from the LSK GFP subsets or 5 Â 10 4 cells from whole bone marrow were cultured in Methocult M3334 (StemCell Technologies). Colonies were assigned scores after 2-4 d of culture according to criteria in the technical manual provided with the assay media (StemCell Technologies). For the multilineage colony assay, 2.5 Â 10 2 cells from the LK subsets, 1 Â 10 2 cells from the sorted LSK subsets or 2.5 Â 10 4 cells from nucleated bone marrow were cultured in Methocult M3434 (StemCell Technologies) supplemented with recombinant human thrombopoietin (50 ng/ml), recombinant human IL-11 (50 ng/ml) and recombinant mouse granulocyte-macrophage colony-stimulating factor (5 ng/ml). Colonies were visualized with an inverted bright field microscope (Nikon TMS) and were assigned scores from day 5 to day 17 as decribed 37 . The identity of colonies was confirmed by staining of individually picked colonies with MayGiemsa (Harleco) followed by examination with a brightfield microscope (Olympus BX50). Colony images were captured with an inverted fluorescent microscope (Axiovert 200M; Zeiss). Cytospins were done in a Cytospin 4 (ThermoShandon) at 500-1,000g for 4-5 min. Cytokines were purchased from StemCell Technologies and R&D Systems.
